Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy Volunteers

Clinical trial NCT06982508 · RECRUITING

Trial details

NCT number: NCT06982508
Sponsor: NewAmsterdam Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Antioxidant Absorption

Start date: 2025-09-09
Primary completion: 2026-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.